Author:
Dworkin R.H.,Peirce-Sandner S.,Turk D.C.,McDermott M.P.,Gibofsky A.,Simon L.S.,Farrar J.T.,Katz N.P.
Subject
Orthopedics and Sports Medicine,Biomedical Engineering,Rheumatology
Reference58 articles.
1. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials;Bjordal;Eur J Pain,2007
2. OARSI recommendations for the management of hip and knee osteoarthritis, part III: changes in evidence following systematic cumulative update of research published through January 2009;Zhang;Osteoarthritis Cartilage,2010
3. U.S. Department of Health and Human Services. Guidance for industry: E10 choice of control group and related issues in clinical trials, 2001; Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm073139.pdf.
4. U.S. Department of Health and Human Services. Guidance for industry: clinical development programs for drugs, devices, and biological products intended for the treatment of osteoarthritis (OA), 1999; Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071579.pdf.
5. OMERACT–OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited;Pham;Osteoarthritis Cartilage,2004
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献